Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Skin Pharmacol Physiol ; 33(3): 82-92, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32535609

RESUMEN

BACKGROUND: Essential oil derived from Chamaecyparis obtusa (EOCO) has been used as an alternative treatment for allergy-related diseases due to its immune-modulating characteristics. Clothing has the longest and most intense contact with human skin, and functional fabrics with intrinsic properties have been increasingly implemented in medical applications. Specially designed fabrics may support atopic dermatitis (AD) treatment. In this study, the effects of fabric containing EOCO on AD were investigated using an NC/Nga mouse model. METHODS: The fabric was applied for 6 h per day for 14 days. The therapeutic effects were evaluated according to measurements of skin lesion severity (modified SCORAD score), transepidermal water loss (TEWL), serum IgE and inflammatory cytokine levels, lesion thickness measured after hematoxylin and eosin staining, and immunohistochemical and Western blot analysis for skin epidermal differentiation protein. RESULTS: The EOCO group exhibited significantly reduced modified SCORAD score, TEWL, and serum IgE levels. Among the inflammatory cytokines analyzed, only the mean values of regulated on activation, normal T cell expressed and secreted were observed to be decreased compared with other control groups. The histological analysis of the skin also revealed that the EOCO group expressed reduced epidermal hyperplasia and recovered filaggrin, involucrin, and loricrin expression. CONCLUSIONS: It was confirmed that fabric containing EOCO has anti-atopic and anti-inflammatory properties. The study data show that fabric containing EOCO can be implemented as an alternative functional clothing for people suffering from AD.


Asunto(s)
Antiinflamatorios/uso terapéutico , Chamaecyparis , Vestuario , Dermatitis Atópica/terapia , Aceites Volátiles/uso terapéutico , Animales , Antiinflamatorios/farmacología , Fibra de Algodón , Citocinas/sangre , Dermatitis Atópica/sangre , Dermatitis Atópica/metabolismo , Dermatitis Atópica/patología , Proteínas Filagrina , Inmunoglobulina E/sangre , Proteínas de Filamentos Intermediarios/metabolismo , Masculino , Proteínas de la Membrana/metabolismo , Ratones , Aceites Volátiles/farmacología , Fitoterapia , Precursores de Proteínas/metabolismo , Piel/efectos de los fármacos , Piel/metabolismo , Piel/patología
2.
Biosci Biotechnol Biochem ; 80(1): 203-9, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26581235

RESUMEN

Chamaecyparis obtusa essential oil (COE) has been widely used to treat allergic diseases and was suggested to exert anti-inflammatory, antioxidant, and antimicrobial effects. This study evaluated the effects of COE on pain-related behavior and pro-inflammatory cytokines in rats with carrageenan (CGN)-induced arthritis. Reduced dynamic weight load on inflamed joint in voluntarily walking rats was used as the behavior test for arthritic pain; 10% COE-treated group was significantly attenuated pain (6-8 h post-CGN injection) compared to VEH (mineral oil)-treated group. In addition, the protein levels of interleukin (IL)-1ß, tumor necrosis factor-α, IL-6 (6-8 h), and cyclooxygenase (COX)-2 (8 h) within the synovial membrane, as well as IL-1ß, COX-2 (6-8 h), and IL-6 (5-7 h) within the meniscus, of 10% COE-treated group were significantly reduced. The current results implicate that COE has anti-inflammatory and anti-nociceptive effects on arthritis in rats.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Artritis Experimental/tratamiento farmacológico , Chamaecyparis/química , Aceites Volátiles/farmacología , Dolor/tratamiento farmacológico , Fitoterapia/métodos , Analgésicos/aislamiento & purificación , Animales , Antiinflamatorios/aislamiento & purificación , Artritis Experimental/inducido químicamente , Artritis Experimental/fisiopatología , Carragenina , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Expresión Génica , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Interleucina-6/genética , Interleucina-6/metabolismo , Masculino , Aceites Volátiles/aislamiento & purificación , Dolor/inducido químicamente , Dolor/fisiopatología , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley , Membrana Sinovial/efectos de los fármacos , Membrana Sinovial/fisiopatología , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...